131 related articles for article (PubMed ID: 35123773)
41. Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.
Hauschild A; Larkin J; Ribas A; Dréno B; Flaherty KT; Ascierto PA; Lewis KD; McKenna E; Zhu Q; Mun Y; McArthur GA
JAMA Oncol; 2018 Oct; 4(10):1382-1388. PubMed ID: 30073321
[TBL] [Abstract][Full Text] [Related]
42. [Features and clinical significance of gene mutations in patients with myelodysplastic syndromes with ring sideroblasts].
Cai YN; Xu ZF; Li B; Qin TJ; Pan LJ; Qu SQ; Hu NB; Liu D; Huang HJ; Shi ZX; Zhang YD; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2020 May; 41(5):379-386. PubMed ID: 32536134
[No Abstract] [Full Text] [Related]
43. Prevalence of NRAS Mutation, PD-L1 Expression and Amplification, and Overall Survival Analysis in 36 Primary Vaginal Melanomas.
Wang HY; Wu XY; Zhang X; Yang XH; Long YK; Feng YF; Wang F
Oncologist; 2020 Feb; 25(2):e291-e301. PubMed ID: 32043781
[TBL] [Abstract][Full Text] [Related]
44. Vulvar/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities.
Mert I; Semaan A; Winer I; Morris RT; Ali-Fehmi R
Int J Gynecol Cancer; 2013 Jul; 23(6):1118-25. PubMed ID: 23765206
[TBL] [Abstract][Full Text] [Related]
45. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
Griewank KG; Murali R; Puig-Butille JA; Schilling B; Livingstone E; Potrony M; Carrera C; Schimming T; Möller I; Schwamborn M; Sucker A; Hillen U; Badenas C; Malvehy J; Zimmer L; Scherag A; Puig S; Schadendorf D
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25217772
[TBL] [Abstract][Full Text] [Related]
46. Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report.
Inoue K; Tsubamoto H; Isono-Nakata R; Sakata K; Nakagomi N
BMC Cancer; 2018 Jun; 18(1):630. PubMed ID: 29866134
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma.
Liu DH; Zhao ZR; Lin YB; Zhou WJ; Hou JY; Ye ZH; Long H
Ann Surg Oncol; 2019 Jun; 26(6):1934-1941. PubMed ID: 30820786
[TBL] [Abstract][Full Text] [Related]
48. The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
Karachaliou GS; Alkallas R; Carroll SB; Caressi C; Zakria D; Patel NM; Trembath DG; Ezzell JA; Pegna GJ; Googe PB; Galeotti JP; Ayvali F; Collichio FA; Lee CB; Ollila DW; Gulley ML; Johnson DB; Kim KB; Watson IR; Moschos SJ
BMC Cancer; 2022 Jan; 22(1):38. PubMed ID: 34986841
[TBL] [Abstract][Full Text] [Related]
49. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
[TBL] [Abstract][Full Text] [Related]
50. Next-generation sequencing revealing TP53 mutation as potential genetic driver in dermal deep-seated melanoma arising in giant congenital nevus in adult patients: A unique case report and review of the literature.
Ricci C; Ambrosi F; Grillini M; Serra M; Melotti B; Gruppioni E; Altimari A; Fiorentino M; Dika E; Lambertini M; Corti B
J Cutan Pathol; 2020 Dec; 47(12):1164-1169. PubMed ID: 32643812
[TBL] [Abstract][Full Text] [Related]
51. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
52. Melanoma of the Skin in the Danish Cancer Registry and the Danish Melanoma Database: A Validation Study.
Pedersen SA; Schmidt SAJ; Klausen S; Pottegård A; Friis S; Hölmich LR; Gaist D
Epidemiology; 2018 May; 29(3):442-447. PubMed ID: 29337844
[TBL] [Abstract][Full Text] [Related]
53. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.
Sheng X; Kong Y; Li Y; Zhang Q; Si L; Cui C; Chi Z; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Dai J; Guo J
Eur J Cancer; 2016 Sep; 65():156-63. PubMed ID: 27498141
[TBL] [Abstract][Full Text] [Related]
54. Predominance of triple wild-type and IGF2R mutations in mucosal melanomas.
Iida Y; Salomon MP; Hata K; Tran K; Ohe S; Griffiths CF; Hsu SC; Nelson N; Hoon DSB
BMC Cancer; 2018 Oct; 18(1):1054. PubMed ID: 30373548
[TBL] [Abstract][Full Text] [Related]
55. Germline mutation in the TP53 gene in uveal melanoma.
Hajkova N; Hojny J; Nemejcova K; Dundr P; Ulrych J; Jirsova K; Glezgova J; Ticha I
Sci Rep; 2018 May; 8(1):7618. PubMed ID: 29769598
[TBL] [Abstract][Full Text] [Related]
56. TP53 gene mutations and protein accumulation in primary vaginal carcinomas.
Skomedal H; Kristensen G; Helland A; Nesland JM; Kooi S; Børresen AL; Holm R
Br J Cancer; 1995 Jul; 72(1):129-33. PubMed ID: 7599041
[TBL] [Abstract][Full Text] [Related]
57. Malignant Melanoma of the Female Genital Tract: Experience of an Oncology Center in Pakistan.
Shakeel O; Ullah F; Khalid N; Ali SI; Batool S; Amjad A; Anwer AW; Ali H; Zafar H; Syed AA
Cureus; 2020 Jun; 12(6):e8484. PubMed ID: 32642388
[TBL] [Abstract][Full Text] [Related]
58. Real-world Outcomes of First-line Anti-PD-1 Therapy for Advanced Melanoma: A Nationwide Population-based Study.
van Zeijl MCT; Haanen JBAG; Wouters MWJM; de Wreede LC; Jochems A; Aarts MJB; van den Berkmortel FWPJ; de Groot JWB; Hospers GAP; Kapiteijn EW; Piersma D; van Rijn RS; Suijkerbuijk KPM; Ten Tije AJ; van der Veldt AAM; Vreugdenhil G; van der Hoeven KJM; van den Eertwegh AJM
J Immunother; 2020 Oct; 43(8):256-264. PubMed ID: 32804914
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
Qin K; Hou H; Liang Y; Zhang X
BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
[TBL] [Abstract][Full Text] [Related]
60. Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases.
Helvind NM; Hölmich LR; Smith S; Glud M; Andersen KK; Dalton SO; Drzewiecki KT
JAMA Dermatol; 2015 Oct; 151(10):1087-95. PubMed ID: 26061591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]